<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01959178</url>
  </required_header>
  <id_info>
    <org_study_id>825E</org_study_id>
    <nct_id>NCT01959178</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate a Mid Add Multi-Focal Soft Contact Lens</brief_title>
  <official_title>A Study to Evaluate a Mid Add Multi-Focal Soft Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluate the product performance of the investigational LD127025 MF mid add&#xD;
      soft contact lens compared to CIBA Vision's Air Optix Aqua MF MED add soft contact lenses&#xD;
      when used among currently adapted soft contact lens wearers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Visual Acuity</measure>
    <time_frame>At 1 Week follow up</time_frame>
    <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms/Complaints</measure>
    <time_frame>At 1 Week follow up</time_frame>
    <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">146</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>LD127025 MF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mid add daily disposable soft contact lens worn on a daily wear basis for 1 week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air Optix Aqua MF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Medium add daily disposable soft contact lens worn on a daily wear basis for one week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LD127025 MF</intervention_name>
    <description>At Visit 1, one-half of the subjects will be randomized to receive the investigational soft contact lens, after approximately one week of wearing the first lens type, the subjects will return for the 1-Week Crossover Visit (Visit 2) for an exam, and to determine if the subject remains eligible to continue in the next phase of the study with the control soft contact lens.</description>
    <arm_group_label>Air Optix Aqua MF</arm_group_label>
    <arm_group_label>LD127025 MF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Air Optix Aqua MF</intervention_name>
    <description>At Visit 1, one-half of the subjects will be randomized to receive the control soft contact lens, after approximately one week of wearing the first lens type, the subjects will return for the 1-Week Crossover Visit (Visit 2) for an exam, and to determine if the subject remains eligible to continue in the next phase of the study with the investigational soft contact lens.</description>
    <arm_group_label>Air Optix Aqua MF</arm_group_label>
    <arm_group_label>LD127025 MF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Have physiologically normal anterior segments not exhibiting biomicroscopy findings&#xD;
             Grade 2 or greater and/or presence of infiltrates.&#xD;
&#xD;
          -  Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must&#xD;
             be of the same manufacture and brand.&#xD;
&#xD;
          -  Be correctable through spherocylindrical refraction to 42 letters (0.1 logMAR) or&#xD;
             better (distance, high contrast) in each eye.&#xD;
&#xD;
          -  Require contact lens correction from -5.00 D to +3.00 D in each eye.&#xD;
&#xD;
          -  Be Presbyopic and require near add correction from +1.00 D to +1.75 D in each eye.&#xD;
&#xD;
          -  Be an adapted monovision soft contact lens wearer or multifocal soft contact lens&#xD;
             wearer or an adapted spherical soft contact lens wearer who also uses spectacles for&#xD;
             near vision correction.&#xD;
&#xD;
          -  Be willing to use a lens care system as required by the lens replacement schedule.&#xD;
&#xD;
          -  Has a distance spherical equivalent refraction between -5.50 D and +3.00 D.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not correctable to 32 letters (0.3 logMAR) in each eye with soft spherical contact&#xD;
             lenses.&#xD;
&#xD;
          -  Participated in any drug or device clinical investigation (within 14 days) prior to&#xD;
             entry into this study and/or during the period of study participation.&#xD;
&#xD;
          -  Women of childbearing potential if one of the following: pregnant, plans to become&#xD;
             pregnant during study, is breast-feeding.&#xD;
&#xD;
          -  Any Grade 2 or greater finding during the slit lamp examination. Subjects with corneal&#xD;
             infiltrates of ANY GRADE are not eligible.&#xD;
&#xD;
          -  Any scar or neovascularization within the central 4mm of the cornea. Subjects with&#xD;
             minor peripheral corneal scarring (that does not extend into the central area), that&#xD;
             in the Investigator's judgment, does not interfere with contact lens wear, are&#xD;
             eligible for this study.&#xD;
&#xD;
          -  Any &quot;Present&quot; finding during the slit lamp examination that, in the Investigator's&#xD;
             judgment, interferes with contact lens wear.&#xD;
&#xD;
          -  Anisometropia (spherical equivalent) of greater than 2.00 D.&#xD;
&#xD;
          -  Aphakic.&#xD;
&#xD;
          -  Amblyopic.&#xD;
&#xD;
          -  Allergic to any component in the study care products.&#xD;
&#xD;
          -  Meet any of the following criteria:&#xD;
&#xD;
          -  Ophthalmologist, OD, Optician, Ophthalmologist's Assistant/Technician&#xD;
&#xD;
          -  employee of a market research firm&#xD;
&#xD;
          -  employee of manufacturer of contact lens or contact lens care products&#xD;
&#xD;
          -  Ocular astigmatism of greater than 1.00 D in either eye.&#xD;
&#xD;
          -  Have had any corneal surgery (ie, refractive surgery).&#xD;
&#xD;
          -  Toric contact lens wearer.&#xD;
&#xD;
          -  Have worn gas permeable (GP) contact lenses within the last 30 days or PMMA lenses&#xD;
             within the last 3 months.&#xD;
&#xD;
          -  Have an active ocular disease or are using any ocular medication.&#xD;
&#xD;
          -  Have any systemic disease currently affecting ocular health or which, in the&#xD;
             Investigator's opinion, may have an effect on ocular health during the course of the&#xD;
             study.&#xD;
&#xD;
          -  Using any systemic medications that will, in the Investigator's opinion, affect ocular&#xD;
             physiology or lens performance.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Stefffen</last_name>
    <role>Study Director</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bausch &amp; Lomb Incorporated</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 8, 2013</study_first_submitted>
  <study_first_submitted_qc>October 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2013</study_first_posted>
  <results_first_submitted>August 21, 2020</results_first_submitted>
  <results_first_submitted_qc>September 9, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 30, 2020</results_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>There were 146 participants (292 eyes) were enrolled in this study. One-half of the participants were randomized to receive the investigational lens, and the other half to the control lens. After one week, the participant crossed over to the second lens type for one week.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>LD127025 MF Then Air Optix Aqua MF</title>
          <description>LD127025 MF and then Air Optix Aqua MF after 1 week</description>
        </group>
        <group group_id="P2">
          <title>Air Optix Aqua MF Then LD127025 MF</title>
          <description>Air Optix Aqua MF and then LD127025 MF after 1 week</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="73"/>
                <participants group_id="P2" count="73"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
                <participants group_id="P2" count="71"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Demographics were reported for all eligible, dispensed participants. There was one participant that was not eligible for the study, and thus was excluded.</population>
      <group_list>
        <group group_id="B1">
          <title>Overall Enrolled</title>
          <description>Overall participants enrolled.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="145"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.2" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="110"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Visual Acuity</title>
        <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
        <time_frame>At 1 Week follow up</time_frame>
        <population>Eligible, dispensed eyes assessed for visual acuity are included in the analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>LD127025 MF</title>
            <description>Mid add daily disposable soft contact lens worn on a daily wear basis for 1 week.</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua MF</title>
            <description>Medium add daily disposable soft contact lens worn on a daily wear basis for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Visual Acuity</title>
          <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
          <population>Eligible, dispensed eyes assessed for visual acuity are included in the analysis population.</population>
          <units>logMAR</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="286"/>
                <count group_id="O2" value="288"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.026" spread="0.070"/>
                    <measurement group_id="O2" value="0.008" spread="0.078"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Symptoms/Complaints</title>
        <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
        <time_frame>At 1 Week follow up</time_frame>
        <population>Eligible, dispensed eyes assessed for symptoms/complaints are included in the analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>LD127025 MF</title>
            <description>Mid add daily disposable soft contact lens worn on a daily wear basis for 1 week.</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua MF</title>
            <description>Medium add daily disposable soft contact lens worn on a daily wear basis for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>Symptoms/Complaints</title>
          <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
          <population>Eligible, dispensed eyes assessed for symptoms/complaints are included in the analysis population.</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="141"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="286"/>
                <count group_id="O2" value="282"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Burning/stinging upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.1" spread="9.8"/>
                    <measurement group_id="O2" value="93.4" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.4" spread="8.3"/>
                    <measurement group_id="O2" value="91.4" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort at end of day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.7" spread="19.5"/>
                    <measurement group_id="O2" value="79.9" spread="20.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.3" spread="16.4"/>
                    <measurement group_id="O2" value="84.6" spread="17.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3" spread="13.3"/>
                    <measurement group_id="O2" value="93.5" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.3" spread="16.5"/>
                    <measurement group_id="O2" value="93.6" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dryness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.1" spread="18.2"/>
                    <measurement group_id="O2" value="85.6" spread="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itchiness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.4" spread="10.3"/>
                    <measurement group_id="O2" value="90.2" spread="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.3" spread="7.6"/>
                    <measurement group_id="O2" value="91.0" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall impression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.1" spread="19.7"/>
                    <measurement group_id="O2" value="83.3" spread="19.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Distance vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.0" spread="16.1"/>
                    <measurement group_id="O2" value="82.0" spread="21.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision at intermediate distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.8" spread="21.8"/>
                    <measurement group_id="O2" value="84.4" spread="16.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision at near distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.1" spread="28.6"/>
                    <measurement group_id="O2" value="76.1" spread="22.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.0" spread="23.0"/>
                    <measurement group_id="O2" value="79.5" spread="19.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 weeks</time_frame>
      <desc>Adverse events were not coded. Therefore, source vocabulary is not applicable. Safety data were reported for all eligible, dispensed participants. There was one participant that was not eligible for the study, and thus was excluded.</desc>
      <group_list>
        <group group_id="E1">
          <title>LD127025 MF</title>
          <description>Mid add daily disposable soft contact lens worn on a daily wear basis for 1 week.</description>
        </group>
        <group group_id="E2">
          <title>Air Optix Aqua MF</title>
          <description>Medium add daily disposable soft contact lens worn on a daily wear basis for one week.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="145"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="145"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="145"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="145"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Contact sponsor directly for details.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Bausch Health</organization>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

